Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00053792" target="_blank" >RIV/00216224:14110/11:00053792 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/65269705:_____/11:#0001444
Výsledek na webu
<a href="http://dx.doi.org/10.2478/s11536-011-0055-8" target="_blank" >http://dx.doi.org/10.2478/s11536-011-0055-8</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2478/s11536-011-0055-8" target="_blank" >10.2478/s11536-011-0055-8</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia
Popis výsledku v původním jazyce
Withdrawal-emergent adverse effects of antipsychotics are an infrequently identified condition which can appear during antipsychotic dose reduction and medication change. In this paper, we present the case of severe extrapyramidal symptoms after a dose reduction of risperidone is presented. A patient, 23 years of age, was admitted to a health care facility due to an unexpected change in his behavior, with paranoid delusions, incoherent thinking, and significant anxiety. An initial risperidone treatmentwas soon changed to zuclopenhixol. Subsequently, severe extrapyramidal symptoms appeared, after which the medication was switched back to resperidone. Following this treatment, the patient left the health care facility and stopped the medication of his own volition. Psychotic symptoms and massive extrapyramidal symptoms again occurred. These symptoms subsided only slowly during a subsequent treatment with olanzapine.
Název v anglickém jazyce
Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia
Popis výsledku anglicky
Withdrawal-emergent adverse effects of antipsychotics are an infrequently identified condition which can appear during antipsychotic dose reduction and medication change. In this paper, we present the case of severe extrapyramidal symptoms after a dose reduction of risperidone is presented. A patient, 23 years of age, was admitted to a health care facility due to an unexpected change in his behavior, with paranoid delusions, incoherent thinking, and significant anxiety. An initial risperidone treatmentwas soon changed to zuclopenhixol. Subsequently, severe extrapyramidal symptoms appeared, after which the medication was switched back to resperidone. Following this treatment, the patient left the health care facility and stopped the medication of his own volition. Psychotic symptoms and massive extrapyramidal symptoms again occurred. These symptoms subsided only slowly during a subsequent treatment with olanzapine.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FL - Psychiatrie, sexuologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2011
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Central European Journal of Medicine
ISSN
1895-1058
e-ISSN
—
Svazek periodika
6
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
PL - Polská republika
Počet stran výsledku
3
Strana od-do
662-664
Kód UT WoS článku
000293708800022
EID výsledku v databázi Scopus
—